Inside TC’s Techstars investigation and how AI is accelerating disability tech

May 3, 2024

The downturn in venture capital funding that the world has seen since the bust of the 2021-era bubble has impacted startups, VC firms, and accelerators alike. One company in the final category, Techstars, has been shaking up its operations for some time now, leading to certain departures from its ranks. TechCrunch’s deep-dive into how it […]

© 2024 TechCrunch. All rights reserved. For personal use only.

The Download: the cancer vaccine renaissance, and working towards a decarbonized future

May 3, 2024
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Cancer vaccines are having a renaissance Last week, Moderna and Merck launched a large clinical trial in the UK of a promising new cancer therapy: a personalized vaccine that targets a specific set…

Cancer vaccines are having a renaissance

May 3, 2024
This article first appeared in The Checkup, MIT Technology Review’s weekly biotech newsletter. To receive it in your inbox every Thursday, and read articles like this first, sign up here.  Last week, Moderna and Merck launched a large clinical trial in the UK of a promising new cancer therapy: a personalized vaccine that targets a specific set of…